Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,180.80
(
2.71%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
95.65
(
0.86%
)
Bitcoin
70,854.24
(
-0.39%
)
News Focus
News Focus
Post# of 257375
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122859
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Tuesday, 12/20/2005 4:18:00 PM

Tuesday, December 20, 2005 4:18:00 PM

Post# of 257375
Pfizer survey:

The most exciting thing about PFE during 2006 will be:

a) Product launches for Exubera, Sutent, and Indiplon.
b) Resumed growth for Lipitor.
c) Pipeline progress, especially for the HDL-raising drug, Torcetrapib.
d) Cost cutting and improved margins.
e) The dividend yield.
f) None of the above.

--
To vote, please go to
http://www.investorshub.com/boards/board_surveymenu.asp?board_id=1418
and select survey #37.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today